125. Enhance and accelerate human, institutional and infrastructure capacity-building initiatives and promote partnerships in that regard that respond to the specific needs of developing countries in ...
Biological products, such as vaccines, and monoclonal antibodies, offer significant promise in combating global health challenges. However, the limited biomanufacturing capacity in low- and ...